Denali Therapeutics Inc. Common Stock (DNLI) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for DNLI. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 13,034,434 | $250M | INCREASED |
| BAILLIE GIFFORD & CO | 12,066,479 | $232M | DECREASED |
| T. Rowe Price Investment Management, Inc. | 8,519,192 | $164M | INCREASED |
| Temasek Holdings (Private) Ltd | 7,012,974 | $135M | UNCHANGED |
| STATE STREET CORP | 6,272,001 | $120M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP (Director) | AWARD | 19,226 | $378K | 2026-06-03 |
| BAKER BROS. ADVISORS LP (Director) | AWARD | 6,408 | 2026-06-03 | |
| Jennifer E. Cook (Director) | AWARD | 19,226 | $378K | 2026-06-03 |
| Jennifer E. Cook (Director) | AWARD | 6,408 | 2026-06-03 | |
| Timothy Van Hauwermeiren (Director) | AWARD | 19,226 | $378K | 2026-06-03 |
Full institutional holdings, insider history, and congressional trades for Denali Therapeutics Inc. Common Stock on SentiSense.